Ottobock

OBCK · Xetra · EUR

€51.20−1.35%−€0.70

Close · October 2, 2026

Price history

−15.72% over the period
Show chart data

Daily closing prices, adjusted for splits. Long periods: one close per week or month.

DateClose
October 2, 2026€51.20
September 25, 2026€54.50
September 18, 2026€55.50
September 11, 2026€55.80
September 4, 2026€58.30
August 28, 2026€60.10
August 21, 2026€59.70
August 14, 2026€58.00
August 7, 2026€58.30
July 31, 2026€56.10
July 24, 2026€55.40
July 17, 2026€57.50
July 10, 2026€50.10
July 3, 2026€54.10
June 26, 2026€52.00
June 19, 2026€50.30
June 12, 2026€51.00
June 5, 2026€54.70
May 29, 2026€52.80
May 22, 2026€56.10
May 15, 2026€62.00
May 8, 2026€60.00
April 30, 2026€58.30
April 24, 2026€58.60
April 17, 2026€59.10
April 10, 2026€55.00
April 2, 2026€54.05
March 27, 2026€52.65
March 20, 2026€46.42
March 13, 2026€53.30
March 6, 2026€57.60
February 27, 2026€57.00
February 20, 2026€56.95
February 13, 2026€57.40
February 6, 2026€60.85
January 30, 2026€60.75

At a glance

  • The company

    Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and indu

  • Latest results

    Quarter to September 30, 2025 · EPS €0.41

  • Next event

    Quarterly results · November 12, 2026

  • Dividend

    Last ex-dividend on May 20, 2026

Where the price stands

52-wk low€45.56
52-wk high€65.00

−21.23% from the high

Performance

StockDAX
1 month−13.07%−2.35%

Analysts · 8 analysts

Average target€80.38+56.98% vs. price

Buy 7 · Hold 1 · Sell 0

Latest news

All news

The business in numbers

Revenue

€458M

Latest quarter · Q2 2026

Net income

€48.8M

Latest quarter · Q2 2026

Net margin

10.7%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
€3.27B
P/E
25.4
EPS
€2.01
Volume
3.05K
Dividend yield
1.87%

Stocks to explore

Other companies in the Healthcare sector